09887 LEADS BIOLABS-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 3.37X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 1.1% | Net Margin | N/A |
| Total Debt/Equity | 22.2% | Return on Equity | N/A |
| Price/Book | 12.56X | Return on Assets | N/A |
| (HKD 88.950) | 2025-12 | 2024-12 | 2023-12 |
| Net Profit (MHKD) | -235.33 | -320.34 | -399.27 |
|---|---|---|---|
| Net Profit Growth (%) | +26.5 | +19.8 | N/A |
| Earnings Per Share (HKD) | -1.351 | -2.136 | -2.756 |
| Earnings Per Share Growth (%) | +36.7 | +22.5 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A |
| Book NAV (HKD) | 7.084 | N/A | N/A |
| Auditors' Opinion | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 177.255 | 0 | N/A | 8.865 |
| Operating Result | -195.893 | -301.216 | -35.0 | -362.249 |
| Profit Before Taxation | -195.893 | -301.216 | -35.0 | -362.249 |
| Taxation | 15.526 | 0 | N/A | 0 |
| Profit /( Loss) After Taxation | -211.419 | -301.216 | -29.8 | -362.249 |
| Net Profit | -211.419 | -301.216 | -29.8 | -362.249 |
| Earnings Per Share () | -1.3513 | -2.1356 | -36.7 | -2.7564 |
| Announcement Date | 2026-03-27 | 2025-07-17 | NA | 2025-07-17 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
